Bright Minds Biosciences Inc. Insider Ownership | DRUG

Insider Holdings by Owner

950.00K Shares

Insider Ownership Statistics

as of 30 Sep, 2026

Insider Ownership

25.89%

■0% pp QoQ

Shares Held by Insiders

2.01Mn

filed for Sep 2026

■0.00% QoQ

Shares Outstanding

7.76Mn

7,761,288 shares

Direct Holdings

0

Indirect: 2.01Mn

Net Shares Traded (QoQ)

0

no net change in Sep 2026

Insiders Holding Shares

1

with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold

Latest quarter —

Net over range —

Buying quarters —

Insider Ownership Summary

Quarter ending 30 Sep, 2026

As of August 29, 2026, the three largest insider holders of DRUG are Asset Management, Lp Cormorant (TenPercentOwner, 1.06Mn shares), Asset Management, Lp Cormorant (Other, 950.00K shares).

A detailed ownership breakdown for Bright Minds Biosciences is not available at this time.
Insider holdings in DRUG account for 2921.37% of outstanding stock, totaling 2.01Mn shares from a 6.88Mn share base, per Business Quant data.
These holdings increased 89.68% from the prior quarter, rising from 1.06Mn to 2.01Mn shares at Bright Minds Biosciences.
There were no significant purchases by Bright Minds Biosciences's insiders in the last 90 days.
Bright Minds Biosciences had no significant insider sales in the last 90 days.

Form 4 Holdings

Insiders Holding DRUG

Insiders 1

Shares held 950.00K

Of outstanding 12.24%

#	Insider	Position	Direct	Indirect	Total	Share of Insiders	Last Filed
1	Asset Management, Lp Cormorant	Other	0	950,000	950,000	100.0%	30 Apr, 2026

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

13 Insider Transactions

Source SEC Form 4

Latest quarter Sep 2026

Date	Insider	Position	Transaction	Shares	Price	Value	Shares Held After	Ownership
28 Apr, 2026	Asset Management, Lp Cormorant	Other	Disposed S	109,331	$89.50	$9.79Mn	950,000	Indirect
04 Nov, 2024	Asset Management, Lp Cormorant	TenPercentOwner	Acquired P	184,331	$21.70	$4.00Mn	1,059,331	Indirect
15 Oct, 2024	Asset Management, Lp Cormorant	TenPercentOwner	Acquired P	238,097	$4.53	$1.08Mn	690,506	Indirect
15 Oct, 2024	Asset Management, Lp Cormorant	TenPercentOwner	Acquired P	63,173	$5.92	$374.24K	753,679	Indirect
15 Oct, 2024	Asset Management, Lp Cormorant	TenPercentOwner	Acquired P	33,343	$6.42	$214.22K	787,022	Indirect
15 Oct, 2024	Asset Management, Lp Cormorant	TenPercentOwner	Acquired P	8,900	$7.31	$65.02K	795,922	Indirect
15 Oct, 2024	Asset Management, Lp Cormorant	TenPercentOwner	Acquired P	2,600	$8.80	$22.89K	798,522	Indirect
15 Oct, 2024	Asset Management, Lp Cormorant	TenPercentOwner	Acquired P	2,700	$9.26	$25.01K	801,222	Indirect
15 Oct, 2024	Asset Management, Lp Cormorant	TenPercentOwner	Acquired P	19,169	$11.72	$224.60K	820,391	Indirect
15 Oct, 2024	Asset Management, Lp Cormorant	TenPercentOwner	Acquired P	4,609	$12.35	$56.93K	825,000	Indirect
16 Oct, 2024	Asset Management, Lp Cormorant	TenPercentOwner	Acquired P	39,743	$23.22	$922.63K	864,743	Indirect
16 Oct, 2024	Asset Management, Lp Cormorant	TenPercentOwner	Acquired P	7,150	$24.03	$171.81K	871,893	Indirect
16 Oct, 2024	Asset Management, Lp Cormorant	TenPercentOwner	Acquired P	3,107	$25.22	$78.36K	875,000	Indirect

Bright Minds Biosciences DRUG Insider Ownership